Literature DB >> 30076923

Pharmacological evaluation of novel PKR inhibitor indirubin-3-hydrazone in-vitro in cardiac myocytes and in-vivo in wistar rats.

Mary Priyanka Udumula1, Audesh Bhat2, Sureshbabu Mangali1, Jaspreet Kalra1, Indu Dhar3, Dharamrajan Sriram1, Arti Dhar4.   

Abstract

AIMS: Double stranded protein kinase R cellular response is associated with various stress signals such as nutrients, endoplasmic stress, cytokines and mechanical stress. Increased PKR activity has been observed under diabetic and cardiovascular disease conditions. Most of the currently available PKR inhibitors are non-specific and have other effects as well. Thus, the aim of the present study was to examine the effect of novel PKR inhibitor indirubin-3-hydrazone (IHZ) in cultured rat H9C2 cardiomyocytes and wistar rats.
MATERIALS AND METHODS: PKR expression was determined by Q-PCR, immunofluorescence and immunoblotting. The expression of different gene markers for apoptosis was measured by RT-PCR. Apoptosis and oxidative stress were determined by flow cytometry. KEY
FINDINGS: High glucose (HG) treated H9C2 cardiomyocytes and high fructose (HF) treated wistar rats developed a significant increase in PKR expression. A significant increase in apoptosis and generation of reactive oxygen species was also observed in HG treated H9C2 cells and HF treated rats. Reduced vacuole formation and prominent nuclei were also observed in high glucose treated cells. Cardiac hypertrophy and increased fibrosis were observed in HF treated rats. All these effects of HG and HF were attenuated by novel PKR inhibitor, indirubin-3-hydrazone. SIGNIFICANCE: Our results indicate IHZ as an effective inhibitor of PKR in vitro and in-vivo, thus it may prove very useful in blocking the multiple harmful effects of PKR.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyocytes; High fructose; High glucose; Indirubin-3-hydrazone

Mesh:

Substances:

Year:  2018        PMID: 30076923     DOI: 10.1016/j.lfs.2018.07.055

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases.

Authors:  Esam S B Salem; Andrew D Vonberg; Vishnupriya J Borra; Rupinder K Gill; Takahisa Nakamura
Journal:  Front Cardiovasc Med       Date:  2019-08-20

2.  Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R.

Authors:  Jozaa Z ALTamimi; Mona N BinMowyna; Nora A AlFaris; Reham I Alagal; Attalla F El-Kott; Ammar M Al-Farga
Journal:  Saudi Pharm J       Date:  2020-12-14       Impact factor: 4.330

3.  High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats.

Authors:  Mary Priyanka Udumula; Sureshbabu Mangali; Jaspreet Kalra; Deepika Dasari; Srashti Goyal; Vandana Krishna; Srivarsha Reddy Bollareddy; Dharamrajan Sriram; Arti Dhar; Audesh Bhat
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

Review 4.  PKR: A Kinase to Remember.

Authors:  Shunit Gal-Ben-Ari; Iliana Barrera; Marcelo Ehrlich; Kobi Rosenblum
Journal:  Front Mol Neurosci       Date:  2019-01-09       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.